Skip to content

MABVAX THERAPEUTICS HOLDINGS, INC.: filings

Every MABVAX THERAPEUTICS HOLDINGS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 32 filings, each linked to its SEC index.

Filing record ends 2018-11-13

The latest filing in this captured record is a 10-Q filed 2018-11-13. No later filing is in the SEC companyfacts record captured on 2026-09-22. MABVAX THERAPEUTICS HOLDINGS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2018-11-13fiscal Q3 2018361030001654954-18-012555
10-Q2018-10-15fiscal Q2 201829770001654954-18-011104
10-Q2018-10-15fiscal Q1 201827550001654954-18-011103
10-K/A2018-10-15fiscal FY 201735680001654954-18-011102
10-K2018-04-02fiscal FY 201735680001654954-18-003518
10-Q2017-11-07fiscal Q3 201729770001654954-17-010141
10-Q2017-08-14fiscal Q2 201728750001654954-17-007586
10-Q2017-05-22fiscal Q1 201728570001654954-17-004995
10-K2017-03-01fiscal FY 201635680001654954-17-001584
10-Q2016-11-07fiscal Q3 201628730001654954-16-003593
10-Q2016-08-11fiscal Q2 201628730001415889-16-006776
10-Q2016-05-09fiscal Q1 201628560001415889-16-005790
10-K2016-03-14fiscal FY 201531620001415889-16-005062
10-Q2015-10-30fiscal Q3 201526700001415889-15-003548
10-Q2015-08-10fiscal Q2 201526680001415889-15-002593
10-Q2015-05-15fiscal Q1 201525510001415889-15-001736
10-K/A2015-04-02fiscal FY 201434660001193125-15-117877
10-Q/A2015-03-25fiscal Q3 201424630001193125-15-105139
10-Q2014-11-14fiscal Q3 201426650001193125-14-412883
10-Q2014-08-08fiscal Q2 201420550001193125-14-302368
10-Q2014-05-15fiscal Q1 201418370001193125-14-201345
10-K2014-03-10fiscal FY 2013231040001193125-14-091700
10-Q2013-11-12fiscal Q3 201323600001193125-13-438444
10-Q2013-08-09fiscal Q2 201323600001193125-13-329279
10-Q2013-05-10fiscal Q1 201322450001193125-13-214518
10-K2013-03-15fiscal FY 2012261100001193125-13-110213
10-Q2012-11-09fiscal Q3 201225640001193125-12-463485
10-Q2012-08-10fiscal Q2 201225640001193125-12-350019
10-Q2012-05-09fiscal Q1 201224480001193125-12-222263
10-K2012-02-27fiscal FY 201128720001193125-12-081964
10-Q2011-11-04fiscal Q3 201126620001193125-11-297252
10-Q2011-08-12fiscal Q2 201126620001193125-11-221593

Inspect the source

Entity
MABVAX THERAPEUTICS HOLDINGS, INC. / CIK 0001109196
Captured
SEC response SHA-256
2dc5df2a7df3f38f707cc55c9468803a1fe6d3f0a8c8a7e3bdc387c99f005336

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001109196.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))